The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Humulin I (Isophane) 100 IU/ml Suspension for Injection in vial



Eli Lilly Nederland B.V.PA2276/002/003

Main Information

Trade NameHumulin I (Isophane) 100 IU/ml Suspension for Injection in vial
Active SubstancesHuman insulin (recombinant dna origin)
Dosage FormSuspension for injection
Licence HolderEli Lilly Nederland B.V.
Licence NumberPA2276/002/003

Group Information

ATC CodeA10AC Insulins and analogues for injection, intermediate-acting
A10AC01 insulin (human)

Status

License statusAuthorised
Licence Issued13/03/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back